P

Inventor

NEUSTADT BERNARD R

US76 patents
⚠️ This page may combine multiple inventors who share the name “NEUSTADT BERNARD R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

49 patents
US6329395B1Dec 11, 2001

Neuropeptide Y5 receptor antagonists

SCHERING CORP186 citations99
US4929641AMay 29, 1990

Mercapto-acylamino acid antihypertensives

SCHERING CORP164 citations99
US4587258AMay 6, 1986

Angiotensin-converting enzyme inhibitors

SCHERING CORP197 citations99
US6689765B2Feb 10, 2004

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP71 citations97
US6391865B1May 21, 2002

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP94 citations97
US6387930B1May 14, 2002

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP76 citations96
US4818749AApr 4, 1989

Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure

SCHERING CORP73 citations96
US4808573AFeb 28, 1989

Carboxyalkyl dipeptides and anti-hypertensive use thereof

SCHERING CORP71 citations96
US6630475B2Oct 7, 2003

Adenosine A2a receptor antagonists

SCHERING CORP53 citations95
US5393755AFeb 28, 1995

Polycyclic guanine derivatives

SCHERING CORP117 citations94
US6204282B1Mar 20, 2001

Benzimidazole compounds that are vitronectin receptor antagonists

SCHERING CORP22 citations93
US5262436ANov 16, 1993

Acylamino acid antihypertensives in the treatment of congestive heart failure

SCHERING CORP23 citations93
US5232920AAug 3, 1993

N-(mercaptoalkyl)amides

SCHERING CORP24 citations93
US5208236AMay 4, 1993

N-(acylaminomethyl)glutaryl amino acids and use

SCHERING CORP38 citations93
US5075302ADec 24, 1991

Mercaptoacyl aminolactam endopeptidase inhibitors

SCHERING CORP37 citations93
US5061710AOct 29, 1991

Mercapto-acylamino acid antihypertensives

SCHERING CORP34 citations93
US4879309ANov 7, 1989

Mercapto-acylamino acids as antihypertensives

SCHERING CORP43 citations93
US4831157AMay 16, 1989

Preparation of angiotensin-converting enzyme inhibitors

SCHERING CORP24 citations93
US4801609AJan 31, 1989

Mercapto-acylamino acid antihypertensives

SCHERING CORP33 citations93
US4470972ASep 11, 1984

7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids

SCHERING CORP46 citations93
US6897217B2May 24, 2005

2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

SCHERING CORP25 citations92
US6602885B2Aug 5, 2003

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP21 citations92
US5298492AMar 29, 1994

Diamino acid derivatives as antihypertensives

SCHERING CORP45 citations92
US6875772B2Apr 5, 2005

[1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists

SCHERING CORP16 citations84
US7041666B2May 9, 2006

Adenosine A2a receptor antagonists

SCHERING CORP13 citations83
US6228985B1May 8, 2001

Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents

SCHERING CORP19 citations83
US4230635AOct 28, 1980

Substituted 4'-polyhaloisopropylsulfonanilides

SCHERING CORP22 citations82
US4199597AApr 22, 1980

Omega-(4-polyfluoro-2-hydroxy-2-propyl)-2,3,6-substituted-phenoxy and phenylthio)alkanoic acids and compounds related thereto

SCHERING CORP22 citations82
US4093742AJun 6, 1978

Anti-hypertensive polyhaloisopropyl-substituted arylureas

SCHERING CORP20 citations82
US7078408B2Jul 18, 2006

[1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists

SCHERING CORP6 citations74
US5348944ASep 20, 1994

Carboxyalkyl dipeptides

SCHERING CORP9 citations74
US4511569AApr 16, 1985

Tricyclic lactams and derivatives useful in increasing cardiac contractility

SCHERING CORP10 citations74
US4379166AApr 5, 1983

Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols

SCHERING CORP16 citations74
US4267193AMay 12, 1981

N-substituted-4-(polyfluoro-2-hydroxy-2-propyl)anilines and compounds related thereto

SCHERING CORP13 citations74
US4081547AMar 28, 1978

Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension

SCHERING CORP4 citations74
US4058612ANov 15, 1977

6-(Polyhaloisopropyl)quinazoline-2,4-diones

SCHERING CORP12 citations74
US7384944B2Jun 10, 2008

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP6 citations73
US6897216B2May 24, 2005

Adenosine A2a receptor antagonists

SCHERING CORP5 citations73
US4840772AJun 20, 1989

Antiglaucoma compositions and methods

SCHERING CORP7 citations73
US4783444ANov 8, 1988

Antiglaucoma compositions and methods

SCHERING CORP12 citations73
US4584285AApr 22, 1986

Antihypertensive agents

SCHERING CORP15 citations73
US4616012AOct 7, 1986

Carboxyalkyl dipeptides as antiglaucoma agents

SCHERING CORP20 citations72
US4559340ADec 17, 1985

Antihypertensive agents

SCHERING CORP14 citations72
US7067655B2Jun 27, 2006

Adenosine A2a receptor antagonists

SCHERING CORP4 citations71
US5356925AOct 18, 1994

N-(mercaptoalkyl)ureas and carbamates

SCHERING CORP9 citations70
US5173506ADec 22, 1992

N-(mercaptoalkyl)ureas and carbamates

SCHERING CORP14 citations70
US4103018AJul 25, 1978

2-[4-(Polyhalo-2-hydroxy-2-propyl)anilino]-2-oxazolin-4-ones and thiazolin-4-ones corresponding thereto

SCHERING CORP8 citations68
US5407960AApr 18, 1995

Mercaptocycloacyl aminoacid endopeptidase inhibitors

SCHERING CORP2 citations63
US5389610AFeb 14, 1995

Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors

SCHERING CORP5 citations63

NEELAMKAVIL SANTHOSH FRANCIS

1 patent

Showing the top 50 of 76 patents by PatentIndex Score.